If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCATCo Regulatory News (CAT)

  • This share is currently suspended. It was suspended at a price of 37.50
  • There is currently no data for CAT

Issue of Equity

9 Dec 2011 08:43

RNS Number : 6782T
CATCo Reinsurance Opps Fund Ltd
09 December 2011
 



THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN OR ANY JURISDICTION IN WHICH SUCH PUBLICATION OR DISTRIBUTION IS UNLAWFUL

 

CATCo Reinsurance Opportunities Fund Ltd.

 

("CATCo" or the "Company")

 

Net Asset Value(s) and Placing Price of new C-shares

 

Net Asset Value(s)

 

 

CATCo Investment Management Ltd, as Company Secretary, announces the unaudited net asset values of the Company's Ordinary Shares and C-shares of USD$1.0801 and USD$1.0314, respectively, as at the close of business on 30 November 2011.

 

On the 15 November 2011 the Board declared a final dividend of USD$0.051 for both the Ordinary and C-shares. The record date was 2 December 2011 and both the Ordinary and C-shares went ex-dividend on 30 November 2011.

 

Issue of new C-shares

 

Further to the announcement of 22 November, CATCo is pleased to announce the placing price of the new C shares to be issued under the Second Closing. A placing price of USD$1.0520 per C-share was calculated as the net asset value per C-share as at the close of business on 30 November 2011 plus 2 per cent (the "Placing Price"). The issue of new equity is a result of the placing commitments from institutional investors of USD$125 million which were announced to the market on 22 November 2011 (the "Placing").

 

The Placing Price for the new tranche of C-shares is calculated below taking into consideration the Company's dividend declaration:

 

C-share NAV as at 30 November 2011 (Ex-dividend)

USD$1.0314

Issue price for Placing C-share

USD$1.0520

Number of New C-shares to be issued

118,821,292

 

These 118,821,292 new C-shares form the Second Closing of a wider placing of up to 400 million New Shares to be admitted to trading on the Specialist Fund Market ("SFM"), which opened on 18 May 2011.

 

Timetable for the Second Closing

 

Admission of the second tranche of C-shares to trading on the London Stock Exchange's Specialist Fund Market

 

16 December 2011

CREST accounts to be credited in respect of the Depository Interests representing the second tranche of C-shares

 

16 December 2011

Admission of the second tranche of C-shares and the existing Ordinary Shares to trading on the Bermuda Stock Exchange

 

16 December 2011

 

Application has been made for these new C-shares to be admitted to trading on the London Stock Exchange's Specialist Fund Market. Trading is expected to commence on 16 December 2011. On Admission the Company will have in issue 87,642,000 Ordinary Shares and 244,118,029 C-shares.

 

Conversion of Second Closing C-shares into Ordinary Shares

 

In respect of the C-shares issued at both the First Closing and to be issued at the Second Closing, it is intended that such C-shares will convert into Ordinary Shares shortly after the date on which the Side Pocket Investment attributable to the New Zealand and the Japanese earthquakes is no longer designated as such and the relevant SP Shares held by the Company in respect of such exposures have converted back into Master Fund Shares.

 

Defined terms used in this Announcement shall have the same meaning as ascribed to them in the Company's Supplementary Prospectus dated 1 December 2011 and Prospectus dated 18 May 2011.

 

For further information contact:

 

CATCo Reinsurance Opportunities Fund Ltd

 

Jason Bibb (Chief Operating Officer)

Mark Way (Corporate Communications Director)

 

 

 

+1 (441) 531 2227

+44 (0) 7786 116 991

Numis Securities Limited

 

David Benda (Corporate Broking)

Hugh Jonathan (Corporate Finance)

Will Kostoris (Corporate Finance)

0207 260 1000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEVKLBBFLFZFBL
Date   Source Headline
18th Dec 20241:48 pmRNSResult of Meeting
18th Dec 20247:30 amRNSSuspension - CATCo Reinsurance Opps Fund Ltd
18th Dec 20247:00 amRNS3rd Quarter Results
22nd Nov 20247:00 amRNSPartial Compulsory Redemption of Shares
18th Nov 20247:00 amRNSCirc re. Proposed winding up and notice of SGM
13th Nov 20247:00 amRNSPartial Compulsory Redemption of Shares
29th Oct 20247:00 amRNSNet Asset Value(s)
1st Oct 20242:40 pmRNSDirector/PDMR Shareholding
1st Oct 20242:40 pmRNSDirector/PDMR Shareholding
27th Sep 20243:05 pmRNSHalf-year Report
4th Sep 20247:00 amRNSNet Asset Value(s)
10th Jun 20247:00 amRNSNet Asset Value(s)
5th Jun 20242:21 pmRNSResult of AGM
24th Apr 20247:00 amRNSFinal Results
23rd Feb 20247:00 amRNSNet Asset Value(s)
23rd Nov 20237:00 amRNSNet Asset Value(s)
26th Sep 20237:00 amRNSHalf-year Report
29th Aug 20237:00 amRNSNet Asset Value(s)
7th Jun 20232:00 pmRNSResult of AGM
17th May 20237:00 amRNSNet Asset Value(s)
26th Apr 20237:00 amRNSFinal Results
16th Feb 20237:00 amRNSNet Asset Value(s)
2nd Dec 20227:00 amRNSHolding(s) in Company
30th Nov 20227:00 amRNSCompulsory Acqn of Shares
21st Nov 202211:42 amRNSCompulsory Acqn of Shares - correction
21st Nov 20227:00 amRNSCompulsory Acqn of Shares
2nd Nov 20227:00 amRNSNet Asset Value(s)
11th Oct 20222:00 pmRNSPrice Monitoring Extension
14th Sep 20227:00 amRNSHalf-year Report
22nd Aug 20227:00 amRNSNet Asset Value(s)
11th Aug 20227:00 amRNSNet Asset Value(s) and Portfolio Update
2nd Aug 202210:38 amRNSHolding(s) in Company
22nd Jul 20227:00 amRNSNet Asset Value(s)
14th Jul 20227:00 amRNSNet Asset Value Reporting Change
12th Jul 20227:00 amRNSNet Asset Value(s)
7th Jun 20227:00 amRNSNet Asset Value(s)
1st Jun 20222:00 pmRNSResult of AGM
3rd May 202212:04 pmRNSDirectorate Change
28th Apr 20227:00 amRNSFinal Results
20th Apr 20224:25 pmRNSHolding(s) in Company
19th Apr 20221:44 pmRNSHolding(s) in Company
13th Apr 20224:41 pmRNSHolding(s) in Company
13th Apr 20222:48 pmRNSHolding(s) in Company
13th Apr 20222:46 pmRNSHolding(s) in Company
7th Apr 20227:00 amRNSPartial Compulsory Redemption of Shares
29th Mar 20227:00 amRNSScheme of arrangement - Closing Date
17th Mar 20227:00 amRNSScheme of arrangement - U.S. Bankruptcy Court
11th Mar 20224:46 pmRNSScheme of arrangement - Sanction of Schemes
10th Mar 20227:00 amRNSSOA - Chairperson’s Report on Scheme Meetings
7th Mar 20227:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.